From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived ...

And Arcutis Biotherapeutics announced approval of roflumilast (Zoryve) topical foam 0.3% for plaque psoriasis of the scalp ...

The outrage over prescription drug pricing in the U.S. is justified. Americans routinely pay two to three times more for ...

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse clinical ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...